Miglustat (ZAVESCA) – Uses, Dosage & Brands in UAE

About Miglustat

Class: | Glycosylceramidase inhibitor Use: | Treatment of type 1 Gaucher disease in patients who are not candidates for enzyme replacement therapy Adult dose: | 100 mg orally three times a day Pediatric dose: | Not established; safety and efficacy in pediatric patients have not been determined Side effects: | Diarrhea, abdominal pain, nausea, headache, fatigue, weight loss, and tremors Contraindications: | Hypersensitivity to Miglustat or any component of the formulation; pregnancy (ca

Drug Class

Glycosylceramidase inhibitor

Uses & Indications

Treatment of type 1 Gaucher disease in patients who are not candidates for enzyme replacement therapy

Storage Requirements

Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture

Manufacturer & Packaging

Manufacturer: Actelion Pharmaceuticals Ltd., UNITED KINGDOM

Package Size

84's (21'S Blister x 4)

Price & Supplier

Price in UAE: AED 56366.10

Dosage Information

Adult Dose

100 mg orally three times a day

Pediatric Dose

Not established; safety and efficacy in pediatric patients have not been determined

Side Effects

Diarrhea, abdominal pain, nausea, headache, fatigue, weight loss, and tremors

Important Warnings

Risk of neurological adverse effects; monitor for signs of peripheral neuropathy; caution in patients with renal impairment; may cause fetal harm if administered during pregnancy

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

Miglustat – Uses, Dosage, and Brands in UAE